Online citations, reference lists, and bibliographies.
← Back to Search

A Study On Drug Delivery Tracing With Radiolabeled Mesoporous Hydroxyapatite Nanoparticles Conjugated With 2DG/DOX For Breast Tumor Cells.

Mahdiyeh Shamsi, Jafar Majidi Zolbanin, B. Mahmoudian, N. M. Zolbanin, L. A. Maleki, M. Jafarabadi, J. Islamian
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Mesoporous nanoparticles have a great potential in targeted therapy approaches due to their ideal properties for encapsulation of various drugs, proteins and also biologically active molecules. MATERIAL AND METHODS We used mesoporous hydroxyapatite (HA) nanoparticles as a drug carrier and developed radiolabeled mesoporous HA containing of 2-deoxy-D-glucose (2DG) and Doxorubicin (DOX) with technetium-99m (99mTc) for imaging in in vitro and in vivo studies. RESULTS 2DG and DOX in presence of mesoporous HA nanoparticles more reduced the fraction of viable cells in the MDA-MB-231, MCF-7 human and MC4-L2 Balb/c mice breast cancer cells. The radiochemical purity of the nano-2DG-DOX complex with 99mTc was calculated to 96.8%. The results of cellular uptake showed a 44.77% increase in uptake of the [99mTc]-nano-2DG-DOX compared to the complex without nanoparticles (p < 0.001). CONCLUSION Radioisotopic imaging demonstrated a high biochemical stability for [99mTc]-nano-2DG-DOX complex. The results demonstrated that [99mTc]-nano-2DG-DOX, may be used as an attractive candidate in cancer imaging and treatment managing.
This paper references
10.1016/j.ijpharm.2016.05.046
Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Negar Abbasi Aval (2016)
APPLICATION OF SUCROSE AS A COSURFACTANT IN CONTROLLING THE PORE DIAMETER IN THE SYNTHESIS OF MESOPOROUS HYDROXYAPATITE NANOPARTICLES
N. A. Aval (2016)
10.1007/978-3-642-10853-2_2
Single photon emission computed tomography tracer.
C. Müller (2013)
10.7314/APJCP.2015.16.5.1683
Nanoparticles promise new methods to boost oncology outcomes in breast cancer.
J. Islamian (2015)
10.1158/0008-5472.CAN-05-3462
Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Kelly K. Andringa (2006)
10.4048/jbc.2012.15.2.141
Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy
F. Aghaee (2012)
10.1016/j.addr.2010.09.015
Molecular imaging with SPECT as a tool for drug development.
C. Gomes (2011)
10.5603/NMR.2011.00016
In vitro and biodistribution examinations of Tc-99m-labelled doxorubicin-loaded nanoparticles.
A. Polyák (2011)
10.4103/0973-1482.55135
Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.
S. Gupta (2009)
10.1016/j.biomaterials.2013.09.094
Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Xinyi Jiang (2014)
10.1016/S1470-2045(06)70793-8
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
M. Yezhelyev (2006)
10.2478/s11535-010-0060-y
2DG enhances the susceptibility of breast cancer cells to doxorubicin
I. Ahmad (2010)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1016/J.APRADISO.2005.08.004
Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors.
Yue Chen (2006)
10.1016/j.nucmedbio.2009.12.006
Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
S. Okarvi (2010)
10.1007/s10549-011-1823-5
Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells
M. Luísa Dória (2011)
10.3109/21691401.2013.785954
Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction
M. Albernaz (2014)
10.1016/j.breast.2017.03.009
Targeted superparamagnetic nanoparticles coated with 2-deoxy-d-gloucose and doxorubicin more sensitize breast cancer cells to ionizing radiation.
J. Pirayesh Islamian (2017)
10.5772/31109
Radiolabeled Nanoparticles for Molecular Imaging
E. Morales-Avila (2012)
10.1038/nrd1007
Molecular imaging in drug discovery and development
M. Rudin (2003)
10.1088/1748-6041/9/2/025012
'Smart' gold nanoshells for combined cancer chemotherapy and hyperthermia.
Zhongshi Liang (2014)
10.2174/09298673113209990218
Multifunctional radiolabeled nanoparticles for targeted therapy.
G. Ferro-Flores (2014)
10.1002/cmmi.1530
Radiolabeling approaches of nanoparticles with (99m) Tc.
D. Psimadas (2013)
Nanotechnology and nuclear medicine; research and preclinical applications.
M. Assadi (2011)
10.1126/science.1125949
Molecular Imaging in Cancer
R. Weissleder (2006)
10.1016/j.ijpharm.2011.11.013
Synthesis and biological evaluation of radiolabeled photosensitizer linked bovine serum albumin nanoparticles as a tumor imaging agent.
Aykut Ozgur (2012)
10.1038/nrd2290
Molecular imaging in drug development
J. Willmann (2008)
10.1021/nn403617j
In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.
F. Chen (2013)
10.1016/j.bmcl.2014.06.051
Synthesis and evaluation of (99m)Tc-2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-D-glucose as a potential tumor imaging agent.
Y. Wang (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar